CIENCIASMEDICASNEWS: Prostate Cancer - mRNA Stabilization in Urine to Aid Diagnosis of Prostate Cancer

sábado, 25 de agosto de 2018

Prostate Cancer - mRNA Stabilization in Urine to Aid Diagnosis of Prostate Cancer

	August 23, 2018
	Prostate Cancer
	The latest prostate cancer news from News Medical

mRNA Stabilization in Urine to Aid Diagnosis of Prostate Cancer

Expression of PSA mRNA in urine and blood are more suitable for prostate cancer diagnosis but they require urine samples to be immediately frozen, otherwise nucleic acids may break down before detection.

Read Full Article Here

			Offspring fed with low-protein diet during pregnancy more likely to develop prostate cancer The offspring of females fed a low-protein diet during pregnancy and lactation are significantly more likely to develop prostate cancer as they age.

			Radical radiotherapy that reduces treatment to just 5 days could benefit men with prostate cancer Early results from an innovative new clinical trial led by researchers from Queen's University Belfast have shown that men with prostate cancer could benefit from radical radiotherapy that delivers treatment in just five visits instead of the usual 37.

	Timing of dinner associated with breast and prostate cancer risks A new International Journal of Cancer study reveals that eating an early supper and having a long interval between the last meal and sleep are associated with lower breast and prostate cancer risks.

	Genetic sequencing reveals new clues to aggressiveness of prostate cancer Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common.

	Researchers uncover cause for progression of prostate cancer to incurable stage Researchers at the University of Oulu in Finland have discovered novel genes and mechanisms that can explain how a genomic variant in a single nucleotide polymorphism rs11672691 influences prostate cancer aggressiveness.

	Study: Blood test can predict response of advanced prostate cancer patients to treatments An international collaborative study between Lawson Health Research Institute, Memorial Sloan Kettering Cancer Center, the Royal Marsden and Epic Sciences is one of the first to demonstrate that a blood test can predict how patients with advanced prostate cancer will respond to specific treatments, leading to improved survival.